Brazil authorizes the use of Chinese and Astrazeneca emergencies

The National Agency for Sanitary Vigilance (Anvisa) authorizes this domino to use the emergence character of the Chinese laboratory labs Sinovac and the Anglo-Swedish AstraZeneca, last step to initiate the immunization in Brazil, one of the most massive countries.

By unanimity, the five members of the board of directors of the governor authorizing this domino to use the emergence of antidote ambush, through a meeting of five hours, which were transmitted live, and in which to analyze the 50 opinions elaborated tres technical areas.

For the approval of vacancies, only the majority of votes are required, without prejudice to all the members of the Board of Directors opting to favor their use in character of emergence.

Meiruze Freitas, on behalf of the Solicitors, was the first to vote and condition the application of the antidote to the company and publication, before the 28th of February, of a deadline for compromise on the capacity to have the vaccine to estimate the immunological system and produce anticuerpos, by the Butantan Institute, the entity that produces in Brazil the vaccine developed by the Chinese laboratory Sinovac.

Applications for the use of antidotes in the form of emergency firefighting envisage the 8th of January, these days will come, with opening hours different, that will divide the eviction rates of the vacancies.

The first requirement for the “Coronavac” China, which has a 50.4% efficiency and was developed by the Sinovac laboratory and the Butantan Institute, is one of the most prestigious medical research centers in Brazil and is registered with the regional government of Sao Paulo.

The Pauline government consists of 46 million vaccine doses, of which 6 million are available and the rest are in production in Butantán.

I then read about the vacancy unveiled by AstraZeneca and the University of Oxford, which has 70% efficiency and is due to the Gobierno tax on Jair Bolsonaro, which included 100 million doses of the antidote and negotiated the transfer of technology to the Fundaci Cruz (Fiocruz) can produce a total of another 110 million.

One week ago, the governor of the ultra-Orthodox leader decided to include the Chinese vaccine in his national immunization plan and opted to buy the Butantan Institute 100 million antidote doses, including those used in Sao Paulo.

Ambos antidotes will carry out the three phases of testing in Brazil, one of the main requirements required by Anvisa to authorize the use of a vacancy character.

With these vacancies the Gobierno has a green light to start the immunization campaign in Brazil at a time when the second of the pandemic is lost, with the middle of the alert alert for the increase in deaths and contacts Amazon collapsed due to lack of oxygen and hospitalized hospitals.

With around 210,000 deaths, Brazil is the second largest country in the world with a number of bankruptcies, including the United States, and the third nation with the highest number of infected (8.4 million), after North American and Indian countries.

.Source